Document is current
Any future updates will be listed below
-
Authors
Maiorino, Maria Ida https://orcid.org/0000-0003-4659-7546
Di Martino, Nicole
Angelino, Silvia
Maio, Antonietta
Caruso, Paola https://orcid.org/0000-0002-4756-2022
Petrizzo, Michela
Scappaticcio, Lorenzo https://orcid.org/0000-0003-2972-9551
Longo, Miriam https://orcid.org/0000-0002-6459-5854
Forestiere, Daniela
Porcellini, Chiara
Bellastella, Giuseppe https://orcid.org/0000-0002-4748-321X
Giugliano, Dario https://orcid.org/0000-0002-9377-873X
Esposito, Katherine https://orcid.org/0000-0002-3652-5154
- License Information
-
More Information
Article History
Received: 25 June 2025
Accepted: 23 August 2025
First Online: 15 September 2025
Declarations
:
: M.I.M. has participated on speakers bureaus for Eli Lilly, Novo Nordisk and Sanofi. K.E. has been a paid consultant for Sanofi, Novo Nordisk and Roche and has held lectures for Eli Lilly, Lifescan and Bayer. No other potential conflicts of interest relevant to this article were reported.
